These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 9866005)
1. Women's preferences for vaginal antimicrobial contraceptives. I. Methodology. Hardy E; de Pádua KS; Jiménez AL; Zaneveld LJ Contraception; 1998 Oct; 58(4):233-8. PubMed ID: 9866005 [TBL] [Abstract][Full Text] [Related]
2. Women's preferences for vaginal antimicrobial contraceptives. II. Preferred characteristics according to women's age and socioeconomic status. Hardy E; de Pádua KS; Jiménez AL; Zaneveld LJ Contraception; 1998 Oct; 58(4):239-44. PubMed ID: 9866006 [TBL] [Abstract][Full Text] [Related]
3. Women's preferences for vaginal antimicrobial contraceptives. III. Choice of a formulation, applicator, and packaging. Hardy E; Jiménez AL; de Pádua KS; Zaneveld LJ Contraception; 1998 Oct; 58(4):245-9. PubMed ID: 9866007 [TBL] [Abstract][Full Text] [Related]
4. Women's preferences for vaginal antimicrobial contraceptives. IV. Attributes of a formulation that would protect from STD/AIDS. Hardy E; de Pádua KS; Osis MJ; Jiménez AL; Zaneveld LJ Contraception; 1998 Oct; 58(4):251-5. PubMed ID: 9866008 [TBL] [Abstract][Full Text] [Related]
5. Women's preferences for vaginal antimicrobial contraceptives. V: attitudes of Brazilian women to the insertion of vaginal products. Hardy E; de Pádua KS; Hebling EM; Osis MJ; Zaneveld LJ Contraception; 2003 May; 67(5):391-5. PubMed ID: 12742563 [TBL] [Abstract][Full Text] [Related]
6. Easing the way to safer sex. Larkin M Lancet; 1998 Mar; 351(9107):964. PubMed ID: 9734955 [TBL] [Abstract][Full Text] [Related]
7. The promise of public/private sector collaboration in the development of vaginal microbicides. Gabelnick HL; Harper MJ Int J Gynaecol Obstet; 1999 Dec; 67 Suppl 2():S31-8. PubMed ID: 10661739 [TBL] [Abstract][Full Text] [Related]
8. Women's experiences, preferences and perceptions regarding vaginal products: Results from a cross-sectional web-based survey in Portugal. Palmeira-de-Oliveira R; Duarte P; Palmeira-de-Oliveira A; das Neves J; Amaral MH; Breitenfeld L; Martinez-de-Oliveira J Eur J Contracept Reprod Health Care; 2015; 20(4):259-71. PubMed ID: 25529320 [TBL] [Abstract][Full Text] [Related]
9. Female condom acceptability among sex workers in Costa Rica. Madrigal J; Schifter J; Feldblum PJ AIDS Educ Prev; 1998 Apr; 10(2):105-13. PubMed ID: 9573433 [TBL] [Abstract][Full Text] [Related]
10. Microbicide preference among young women in California. Holt BY; Morwitz VG; Ngo L; Harrison PF; Whaley KJ; Pettifor A; Nguyen AH J Womens Health (Larchmt); 2006 Apr; 15(3):281-94. PubMed ID: 16620187 [TBL] [Abstract][Full Text] [Related]
11. Barrier versus oral contraceptive use: a study of female college students. Radius SM; Joffe A; Gall MJ J Am Coll Health; 1991 Sep; 40(2):83-5. PubMed ID: 1939938 [TBL] [Abstract][Full Text] [Related]
13. Challenges of introducing vaginal microbicides in India. Joshi S; Kulkarni V; Paranjape R; Chandhiok N Indian J Med Res; 2009 May; 129(5):618-9. PubMed ID: 19675395 [No Abstract] [Full Text] [Related]
14. [Current status of the female condom in Africa]. Deniaud F Sante; 1997; 7(6):405-15. PubMed ID: 9503499 [TBL] [Abstract][Full Text] [Related]
15. Pushing the frontiers of science--the Population Council's Microbicide Basic Science Network on vaginal microbicide research. Johansson ED; Maguire RA; Phillips DM Int J Gynaecol Obstet; 1999 Dec; 67 Suppl 2():S117-24. PubMed ID: 10661749 [TBL] [Abstract][Full Text] [Related]
16. A randomized, double-blind, placebo-controlled safety and acceptability study of two Invisible Condom formulations in women from Cameroon. Mbopi-Keou FX; Trottier S; Omar RF; Nkele NN; Fokoua S; Mbu ER; Giguere JF; Domingo MC; Piret J; Tsague L; Zekeng L; Mwatha A; Mâsse B; Bergeron MG Contraception; 2009 Nov; 80(5):484-92. PubMed ID: 19835725 [TBL] [Abstract][Full Text] [Related]
17. [Knowledge, attitudes, and practices of Brazilian women treated in the primary health care system concerning sexually transmitted diseases]. Fernandes AM; de Gaspari Antonio D; Bahamondes LG; Cupertino CV Cad Saude Publica; 2000; 16(## Suppl 1):103-12. PubMed ID: 10904393 [TBL] [Abstract][Full Text] [Related]
18. Acceptability of a non-woven device for vaginal drug delivery of microbicides or other active agents. Joanis CL; Hart CW AIDS Behav; 2010 Jun; 14(3):600-6. PubMed ID: 20049522 [TBL] [Abstract][Full Text] [Related]
19. Contraceptive efficacy of a novel spermicidal microbicide used with a diaphragm: a randomized controlled trial. Barnhart KT; Rosenberg MJ; MacKay HT; Blithe DL; Higgins J; Walsh T; Wan L; Thomas M; Creinin MD; Westhoff C; Schlaff W; Archer DF; Ayers C; Kaunitz A; Das S; Moench TR Obstet Gynecol; 2007 Sep; 110(3):577-86. PubMed ID: 17766603 [TBL] [Abstract][Full Text] [Related]
20. Acceptability and preferences for vaginal dosage forms intended for prevention of HIV or HIV and pregnancy. Woodsong C; Holt JD Adv Drug Deliv Rev; 2015 Sep; 92():146-54. PubMed ID: 25703190 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]